H
Huayin Health
Innovative diagnostic solutions for precision medicine, leveraging advanced genomics and bioinformatics technologies
About Huayin Health
Huayin Lab specializes in providing cutting-edge diagnostic solutions aimed at enhancing precision medicine. The company leverages advanced genomics and bioinformatics technologies to offer a comprehensive range of diagnostic tests and services. These services are designed to support healthcare providers, researchers, and pharmaceutical companies in making informed decisions based on genetic data. Operating primarily in the healthcare and biotechnology sectors, Huayin Lab serves a diverse clientele that includes hospitals, clinics, research institutions, and biotech firms. The business model revolves around the development, marketing, and sale of diagnostic tests and related services. Revenue is generated through direct sales of diagnostic kits, subscription-based access to bioinformatics platforms, and customized research services. By focusing on precision medicine, Huayin Lab aims to improve patient outcomes and advance medical research.
Source: Dealroom company dataNews
Open roles
Huayin Health in the Guangzhou ecosystem
The Huayin Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- SGShenZhen GTJA Investment Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Huayin Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Huayin Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.